In final draft guidance published last week, NICE approves rimegepant (Vydura; Pfizer) for preventing episodic migraine in adults where at least three previous preventive treatments have failed.
This interactive video will help you to better understand skin sensitivity and support your customers' skin needs.
The largest, most experienced publisher in the UK pharmacy sector
Pharmacy Magazine is part of The Pharmacy Network, a digital system developed and operated by Communications International Group, the UK's largest provider of pharmacy learning content and publisher of magazines including Pharmacy Magazine, Training Matters, P3pharmacy and Independent Community Pharmacist.
Комментариев нет:
Отправить комментарий